|Tested species reactivity||Human|
|Published species reactivity||Human, Rhesus monkey|
|Host / Isotype||Mouse / IgG2a|
|Contains||0.1% sodium azide|
|Storage Conditions||4° C, store in dark|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Assay-Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
The R-phycoerythrin (PE)-Cy5.5® tandem conjugate permits simultaneous multicolor labeling and detection of multiple targets with excitation by a single excitation source-the 488 nm line of the argon-ion laser.
The CD4 antigen is involved in the recognition of the type II MHC antigen. It is also a receptor for HIV. It is present on most T helper cells and normal thymocytes. The cytoplasmic portion of CD4 is associated with p56lck tyrosine kinase. CD4 expression is commonly found in human lymph nodes and tonsils. CD44 is a type 1 transmembrane glycoprotein also known as Phagocytic Glycoprotein-1 (pgp-1) and HCAM. CD44 is the receptor for hyaluronate and exists as a large number of different isoforms due to alternative RNA splicing. The major isoform expressed on lymphocytes, myeloid cells, and erythrocytes is a glycosylated type 1 transmembrane protein. Other isoforms contain glycosaminoglycans and are expressed on hematopoietic and non-hematopoietic cells. CD44 is involved in adhesion of leukocytes to endothelial cells, stromal cells, and the extracellular matrix.
Analyte Specific Reagent
Selective reduction of IFN-¿ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection.
MHCD0418 was used in flow cytometry to explore how HIV-1 alters immunity during latent tuberculosis
|Riou C,Bunjun R,Müller TL,Kiravu A,Ginbot Z,Oni T,Goliath R,Wilkinson RJ,Burgers WA||Tuberculosis (Edinburgh, Scotland) (101:25)||2016|
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.
MHCD0418 was used in flow cytometry to study the cytolytic effector capacity of HIV-specific CD8+ T cells
|Demers KR,Makedonas G,Buggert M,Eller MA,Ratcliffe SJ,Goonetilleke N,Li CK,Eller LA,Rono K,Maganga L,Nitayaphan S,Kibuuka H,Routy JP,Slifka MK,Haynes BF,McMichael AJ,Bernard NF,Robb ML,Betts MR||PLoS pathogens (12:null)||2016|
|Rhesus monkey||Not Cited||
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs.
MHCD0418 was used in flow cytometry to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques
|Bolton DL,Pegu A,Wang K,McGinnis K,Nason M,Foulds K,Letukas V,Schmidt SD,Chen X,Todd JP,Lifson JD,Rao S,Michael NL,Robb ML,Mascola JR,Koup RA||Journal of virology (90:1321)||2015|
Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates.
MHCD0418 was used in flow cytometry to test if rejection of AAV-transduced hepatocytes is due to AAV capsid-specific CD8 positive T cells that become reactivated upon gene transfer.
|Li H,Lasaro MO,Jia B,Lin SW,Haut LH,High KA,Ertl HC||Molecular therapy : the journal of the American Society of Gene Therapy (19:2021)||2011|
Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans.
MHCD0418 was used in immunocytochemistry to assess the effect of immunosuppression used for organ transplantation on immune responses to adeno-associated virus capsid antigens.
|Parzych EM,Li H,Yin X,Liu Q,Wu TL,Podsakoff GM,High KA,Levine MH,Ertl HC||Human gene therapy (24:431)||2013|
Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.
MHCD0418 was used in flow cytometry to test if anti-CD8 Abs induce effector function.
|Clement M,Ladell K,Ekeruche-Makinde J,Miles JJ,Edwards ES,Dolton G,Williams T,Schauenburg AJ,Cole DK,Lauder SN,Gallimore AM,Godkin AJ,Burrows SR,Price DA,Sewell AK,Wooldridge L||Journal of immunology (Baltimore, Md. : 1950) (187:654)||2011|